Scilex Holding Company Announces Financing Of Up To $25 Million To Enhance Commercialization Of Three Fda Approved Non-Opioid Pain Management Products
Round Type
Funding Round
San DiegoBiotechnologyHealthcareHealth CareDescription
Scilex Holding Company (Nasdaq: SCLX, “Scilex”), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (OTC: SRNEQ), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, announced that it has entered into a securities purchase agreement with YA II PN, Ltd., a Cayman Islands exempt limited partnership managed by Yorkville Advisors Global, LP (”Yorkville”), for the issuance and sale of unsecured convertible debentures in the principal amount of up to $25 million.
Quick answer
Scilex Pharmaceuticals raised an undisclosed amount in a Funding Round round, dated March 21, 2023. Scilex Pharmaceuticals is based in San Diego, California, United States.
- How much did Scilex Pharmaceuticals raise?
- Scilex Pharmaceuticals raised an undisclosed amount in a Funding Round round on March 21, 2023.
- What does Scilex Pharmaceuticals do?
- Scilex Pharmaceuticals is a biopharmaceutical company focused on developing therapies for acute and chronic pain.
- Where is Scilex Pharmaceuticals based and how big is it?
- Scilex Pharmaceuticals is based in San Diego, California, United States.
- Who are the decision-makers at Scilex Pharmaceuticals?
- Fundz holds 1 contact at Scilex Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Scilex Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Optimize Systems raised $6M on May 4, 2023.
- MiCare Path raised $1.2M (Seed) on May 4, 2023.
- Flyte raised $2.6M (Seed) on May 2, 2023.
- Novabay raised $3M (Seed) on May 1, 2023.
- Eximis Surgical raised $8.7M (Funding Round) on April 24, 2023.
- Shape Memory Medical raised $4.8M (Seed) on April 24, 2023.
Who to call at Scilex Pharmaceuticals, and when
A new round usually means Scilex Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Scilex Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Scilex Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Scilex Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Scilex Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Scilex Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.